✦ LIBER ✦

885 THE EFFICACY AND SAFETY OF MIRABEGRON IN PATIENTS WITH OVERACTIVE BLADDER SYNDROME – RESULTS FROM A NORTH-AMERICAN PHASE III TRIAL

✍ Scribed by V. Nitti; S. Herschorn; S. Auerbach; M. Ayers; M. Lee; N. Martin

Book ID: 119623220
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 195 KB
Volume: 10
Category: Article
ISSN: 1569-9056
DOI: 10.1016/s1569-9056(11)60869-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of a Randomized Phase III Trial

Results of a Randomized Phase III Trial of Mirabegron in Patients with Overactive Bladder

✍ Nitti, Victor W.; Auerbach, Stephen; Martin, Nancy; Calhoun, Alaina; Lee, Misun; 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 1022 KB

886 THE EFFICACY AND TOLERABILITY OF MIR

886 THE EFFICACY AND TOLERABILITY OF MIRABEGRON IN PATIENTS WITH OVERACTIVE BLADDER – RESULTS FROM A EUROPEAN–AUSTRALIAN PHASE III TRIAL

✍ V. Khullar; J. Cambronero; P. Ströberg; J. Angulo; P. Boerrigter; M.B. Blauwet; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 226 KB

1959 MIRABEGRON IMPROVES PATIENT-REPORTE

1959 MIRABEGRON IMPROVES PATIENT-REPORTED OUTCOMES IN PATIENTS WITH OVERACTIVE BLADDER SYNDROME - RESULTS FROM A NORTH-AMERICAN STUDY

✍ Nitti, Victor; Herschorn, Sender; Auerbach, Stephen; Martin, Nancy; Blauwet, Mar 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 48 KB

Efficacy and Tolerability of Mirabegron,

Efficacy and Tolerability of Mirabegron, a β3-Adrenoceptor Agonist, in Patients with Overactive Bladder: Results from a Randomised European–Australian Phase 3 Trial

✍ Vik Khullar; Gerard Amarenco; Javier C. Angulo; Javier Cambronero; Kjetil Høye; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 827 KB

Efficacy and Tolerability of Mirabegron,

Efficacy and Tolerability of Mirabegron, a β3-Adrenoceptor Agonist, in Patients with Overactive Bladder: Results from a Randomised European–Australian Phase 3 Trial

✍ Rovner, E.S. 📂 Article 📅 2013 🏛 Elsevier Science ⚖ 51 KB

1958 COMBINATION TREATMENT WITH MIRABEGR

1958 COMBINATION TREATMENT WITH MIRABEGRON AND SOLIFENACIN IN PATIENTS WITH OVERACTIVE BLADDER (OAB) - EFFICACY RESULTS FROM A PHASE 2 STUDY (SYMPHONY)

✍ Abrams, Paul; Kelleher, Con; Staskin, David; Kay, Richard; Martina, Reynaldo Vil 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 237 KB